Single-Agent Subcutaneous Blinatumomab for Advanced B-Cell Acute Lymphoblastic Leukemia: Long-Term Follow-up from a Phase 1b Dose Expansion CohortElias Jabbour, Hagop M. Kantarjian, Vaibhav Agrawal et al.|Blood|2024Cited by 3